News
Explore ICON plc's Q1 2025 earnings call insights, reflecting challenges in clinical trials, operational innovations, and adjusted guidance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback